[1]李 灿,刘 丹,罗常春,等.壮督驱寒合剂对强直性脊柱炎模型小鼠miR-29a及Wnt信号通路的影响*[J].陕西中医,2020,(8):1038-1041.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
　LI Can,LIU Dan,LUO Changchun,et al.Effects of Zhuangdu Quhan mixture on miR-29a and Wnt pathway in the ankylosing spondylitis model mice[J].,2020,(8):1038-1041.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
点击复制

壮督驱寒合剂对强直性脊柱炎模型小鼠miR-29a及Wnt信号通路的影响*

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年8期
页码:
1038-1041
栏目:
基础研究
出版日期:
2020-08-05

文章信息/Info

Title:
Effects of Zhuangdu Quhan mixture on miR-29a and Wnt pathway in the ankylosing spondylitis model mice
作者:
李 灿1; 2; 刘 丹1; 2; 罗常春1; 2; 柳玉佳1; 2; 王莘智1; 2
1.湖南中医药大学(长沙 410208); 2.湖南中医药大学第一附属医院(长沙 410021)
Author(s):
LI Can; LIU Dan; LUO Changchun; et al.
Hunan University of Traditional Chinese Medicine(Changsha 410208)
关键词:
强直性脊柱炎;  壮督驱寒合剂;  miR-29a;  Wnt /β-catenin 信号通路;  小鼠
Keywords:
Ankylosing spondylitis;  Zhuangdu Quhan mixture;  miR-29a;  Wnt/β-catenin signaling pathway;  Mice
分类号:
R593.23
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.006
文献标志码:
A
摘要:
目的:研究壮督驱寒合剂对强直性脊柱炎(AS)模型小鼠miR-29a及Wnt通路的影响,以探讨壮督驱寒合剂防治AS的机制。方法:将50只6～8周Balb/c雌性小鼠随机分为空白组、模型组、西药组、中药低剂量组、中药高剂量组,每组10只。除空白组外,其余各组均采取蛋白聚糖加完全弗式试剂腹腔注射复制AS小鼠模型。造模结束后各组分别进行相应药物灌胃处理,1次/d,连续6周,末次给药后取膝关节滑膜组织。采用实时荧光定量法测定miR-29a、DKK-1及β-catenin的mRNA表达,采用免疫印迹法检测β-catenin、DKK-1蛋白含量。结果:与空白组相比,模型组小鼠滑膜组织中miR-29a表达升高,β-catenin mRNA及蛋白表达升高,DKK-1 mRNA及蛋白表达下降,差异具有统计学意义(P<0.05)。与模型组相比,西药组及中药低、高剂量组miR-29a表达下降,β-catenin mRNA及蛋白表达下降,DKK-1 mRNA及蛋白表达升高,差异具有统计学意义(P<0.05)。结论:壮督驱寒合剂可能通过调控miR-29a来影响Wnt/β-catenin经典信号通路的表达,从而起到延缓AS新骨形成的作用。
Abstract:
Objective:To study the effect of Zhuangdu Quhan mixture(ZQM)on miR-29a and Wnt pathway in ankylosing spondylitis(AS)model mice,and to explore prevention and treatment mechanism of ZQM for AS.Methods:50 Balb/c mice at 6～8 weeks were randomly divided into normal group,western medicine group,model group,and low,high dose ZQM groups,with 10 mice in each group.Except the normal group,proteoglycan and complete Freund's reagent were used to establish AS model in each group.After modeling,the corresponding drugs were administered to each group,and the drug was administered once a day,for 6 weeks.The synovial tissue of the knee joint was taken after the last administration.The mRNA expressions of miR-29a,DKK-1 and β-catenin were determined by real-time fluorescence quantitative method,and the protein contents of β-catenin and DKK-1 were detected by western blot.Results:Compared with the normal group,the expression of miR-29a、β-catenin mRNA and β-catenin protein in the synovial tissue of the model group increased,while the expression of DKK-1 mRNA and DKK-1 protein decreased(P<0.05).Compared with the model group,the expressions of miR-29a,β-catenin mRNA and β-catenin protein decreased,and the expression of DKK-1 mRNA and DKK-1 protein increased in the western medicine group,and low,high dose ZQM groups(P<0.05).Conclusion:Zhuangdu Quhan mixture may regulate the expression of Wnt/β-catenin signaling pathway through miR-29a,thereby delaying the formation of new bone in AS.

参考文献/References:

[1] Stolwijk C,Tubergen A,Castillo JD,et al.Prevalence of extra-articular manifestations in patients with ankylosing spondylitis:a systematic review and meta-analysis[J].Ann Rheum Dis,2015,74(1):65-73.
[2] 吴珊珊,段振华,潘发明.强直性脊柱炎流行病学研究进展[J].安徽医科大学学报,2013,48(8):988-992.
[3] 冯 静,朱 平,冯 媛,等.强直性脊柱炎622例相关因素分析[J].陕西医学杂志,2012,41(2):180-181.
[4] Magrey MN,Khan MA.The paradox of bone formation and bone loss in ankylosing spondylitis:evolving new concepts of bone formation and future trends in management[J].Curr Rheumatol Rep,2017,19(4):17.
[5] Arfat Y,Xiao WZ,Ahmad M,et al.Role of microRNAs in osteoblasts differentiation and bone disorders[J].Curr Med Chem,2015,2(6):748-758.
[6] 杨文雪,夏启胜,陶庆文,等.MicroRNA在强直性脊柱炎成骨、破骨机制中的作用[J].中国骨质疏松杂志,2017,23(3):402-406.
[7] Li C,Zhang P,Gu J.miR-29a modulates tumor necrosis factor-α-induced osteogenic inhibition by targeting Wnt antagonists[J].Dev Growth Differ,2015,57(3):264-273.
[8] Bardos T,Szabo Z,Czipri M,et al.A longitudinal study on an autoimmune murine model of ankylosing spondylitis[J].Ann Rheum Dis,2005,64(7):981-987.
[9] Ishikawa LL,Colavite PM,Rosa LC,et al.Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model[J].Biomed Res Int,2014,2014:148594.
[10] Rielly DD,Uddin M,Rahman P.Ankylosing spondylitis:beyond genome-wide association studies[J].Curr Opin Rheumatol,2016,28(4):337-345.
[11] 勾志静,耿 良.补肾强脊颗粒联合塞来昔布对强直性脊柱炎成纤维细胞抗骨化作用及BMP/Smad信号通路的影响[J].陕西中医,2018,39(9):1194-1197.
[12] Neerinckx B,Lories R.Mechanisms,impact and prevention of pathological bone regeneration in spondyloarthritis[J].Curr Opin Rheumatol,2017,29(4):287-292.
[13] 孟怡辰,冷 峰,周许辉.强直性脊柱炎继发骨质疏松的研究进展[J].中国骨质疏松杂志,2016,22(5):628-631.
[14] Mohammadi H,Hemmatzadeh M,Babaie F,et al.MicroRNA implications in the etiopathogenesis of ankylosing spondylitis[J].J Cell Physiol,2018,233(8):5564-5573.
[15] Kang H,Hata A.The role of microRNAs in cell fate determination of mesenchymal stem cells:balancing adipogenesis and osteogenesis[J].BMB Rep,2015,48(6):319-323.
[16] Arfat Y,Xiao WZ,Ahmad M,et al.Role of microRNAs in osteoblasts differentiation and bone disorders[J].Curr Med Chem,2015,22(6):748-758.
[17] Corr M.Wnt signaling in ankylosing spondylitis[J].Clin Rheumatol,2014,33(6):759-762.
[18] 扶忠超.miR-29a、Dkk-1在强直性脊柱炎患者外周血单个核细胞中的表达及临床意义[D].湛江:广东医学院,2015.

相似文献/References:

[1]郭乃亮.补肾强督治尪汤加减治疗肾虚督寒型强直性脊柱炎疗效及对患者炎症因子的影响[J].陕西中医,2019,(10):1394.
[2]时文才,聂晨旭,胡晓龙,等.黄芪桂枝五物汤合血府逐瘀汤联合针灸治疗早期强直性脊柱炎临床研究*[J].陕西中医,2020,(3):315.
[3]杜 燕,茆春阳,周 波△,等.浅论强直性脊柱炎归于肝*[J].陕西中医,2020,(4):515.
　DU Yan,MAO Chunyang,ZHOU Bo,et al.On ankylosing spondylitis due to the liver[J].,2020,(8):515.
[4]王 培,柳 杨,安艳辰,等.雷火灸联合西药治疗肾虚督寒型强直性脊柱炎临床研究[J].陕西中医,2023,(6):789.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.025]
　WANG Pei,LIU Yang,AN Yanchen,et al.Clinical study on thunder-fire moxibustion combined with western medicine on ankylosing spondylitis of kidney deficiency and governor meridian cold type[J].,2023,(8):789.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.025]
[5]韩 胜,邓素玲,韩小飞,等.推拿经筋手法联合温肾通督汤治疗强直性脊柱炎疗效研究[J].陕西中医,2023,(11):1628.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.033]
　HAN Sheng,DENG Suling,HAN Xiaofei,et al.Curative effect study on massage manipulation combined with Wenshen Tongdu prescription for ankylosing spondylitis[J].,2023,(8):1628.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.033]
[6]吴智龙,殷继超,胡兴律,等.强直性脊柱炎发病与二十四节气相关性研究[J].陕西中医,2024,(1):75.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.017]
　WU Zhilong,YIN Jichao,HU Xinglv,et al.A study on the correlation between the onset of ankylosing spondylitis and the twenty-fourth festival season[J].,2024,(8):75.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.017]
[7]李 吉,李引刚,刘艳平,等.名中医李彦民辨治强直性脊柱炎经验探微[J].陕西中医,2024,(7):967.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.024]
　LI Ji,LI Yingang,LIU Yanping,et al.Exploration of famous traditional Chinese medicine LI Yanmin's clinical experience in treating ankylosing spondylitis[J].,2024,(8):967.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.024]
[8]李锐,王瑞松,黄小强,等.超声引导下小针刀联合神经阻滞治疗强直性脊柱炎腰骶部疼痛疗效研究[J].陕西中医,2025,46(7):997.[doi:DOI:10.3969/j.issn.1000-7369.2025.07.027]
[9]吴梦桐,刘孟娇,杨勇,等.中医药干预强直性脊柱炎相关信号通路研究进展[J].陕西中医,2025,46(7):1002.[doi:DOI:10.3969/j.issn.1000-7369.2025.07.028]
[10]杨会军,杨 静,雷海桃,等.名中医王海东基于“任脉经筋剑突下解结术”治疗强直性脊柱炎经验[J].陕西中医,2026,(5):672.[doi:DOI:10.3969/j.issn.1000-7369.2026.05.017]
　YANG Huijun,YANG Jing,LEI Haitao,et al.Experience of renowned traditional Chinese medicine practitioner WANG Haidong in treating ankylosing spondylitis based on relief technique for knots in the lower part of the xiphoid process of the Ren Meridian[J].,2026,(8):672.[doi:DOI:10.3969/j.issn.1000-7369.2026.05.017]

备注/Memo

备注/Memo:
*湖南省技术创新引导计划资助项目(201761);湖南省中医药管理局资助项目(20177B);中医内科学省部共建教育部重点实验室开放课题(ZYNK201601)
更新日期/Last Update: 2020-08-10